Wusheng Erlunbao: Sinopharm’s First‑of‑Its‑Kind Hexavalent Rotavirus Vaccine Receives NMPA Approval
The Wuhan Institute of Biological Products Co., Ltd., a subsidiary of Sinopharm Group Co., Ltd....
HKG: 1099
Sinopharm Partners with Biogen for Comprehensive Service Agreement
China-based Sinopharm Group Co., Ltd (HKG: 1099) has entered into a strategic partnership with US-based...
Sino Biopharmaceutical and Sinopharm Group Collaborate to Expand Retail Pharmacy Network
In a significant move for China’s pharmaceutical industry, Sino Biopharmaceutical Ltd (HKG: 1177) and Sinopharm...
Lakeside Holding’s Hupan Pharmaceutical Partners with Sinopharm Group Hubei for Supply Chain Services
US-based supply chain solution provider Lakeside Holding Limited (NASDAQ: LSH), which specializes in the Asian...
BI Partners with Sinopharm for Promotion of Sifrol and Pradaxa in China
German pharmaceutical major Boehringer Ingelheim (BI) has entered into a partnership with China-based Sinopharm Group...
Sinopharm Holding Appoints New Chairman and President Following Leadership Changes
Sinopharm Holding (HKG: 1099) has announced significant changes in its leadership with the approval of...
Sinopharm and Fresenius Kabi Expand Partnership to Enhance Drug Distribution and Healthcare Services
China’s state-owned Sinopharm Group Co., Ltd. (HKG: 1099) has announced a new partnership with Germany’s...
Sinopharm Plans to Privatize China Traditional Medicine Holdings in a USD 2 Billion Deal
China Traditional Medicine Holdings (HKG: 0570; China TCM) has announced that its controlling shareholder, the...
Fosun Kite and Medi Cover Launch First Value-Based Payment Plan for Lymphoma Treatment
Fosun Kite and Medi Cover, a health management and patient service platform under Sinopharm (HKG:...
Youcare Pharmaceutical Partners with Sinopharm Heilongjiang to Broaden Market Presence
Youcare Pharmaceutical Group (SHA: 688658), a China-based pharmaceutical company, has entered into a partnership with...
AbbVie Partners with Sinopharm to Enhance Novel Drug Accessibility and Patient Management
US pharmaceutical giant AbbVie (NYSE: ABBV) has entered into a strategic partnership with Sinopharm Group...
Chinese Pharma Consortium Eyes Poland’s Neuca in Strategic European Market Acquisition
A consortium of China-based pharmaceutical companies, potentially including the state-owned giant Sinopharm (HKG: 1099), is...
Sinopharm Partners with Harbin Institute of Technology to Boost Biomedical Industry Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Harbin...
Sinopharm Expands Partnership with Guizhou Government to Boost Health Industry
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strengthened partnership with the...
Sinopharm Partners with Fudan University to Establish National Innovation Platform
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Fudan...
Sinopharm Partners with Shenzhen to Boost High-End Medical Device and Pharmaceutical Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Shenzhen...
Pfizer and Sinopharm Expand Partnership to Enhance Drug Distribution and Lifecycle Solutions
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has announced a strategic partnership with China-based Sinopharm...